- Home
- TMP vs XNCR Comparison
TMP vs XNCR Comparison
Compare TMP & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMP
- XNCR
- Stock Information
- Founded
- TMP 1836
- XNCR 1997
- Country
- TMP United States
- XNCR United States
- Employees
- TMP N/A
- XNCR N/A
- Industry
- TMP Major Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- TMP Finance
- XNCR Health Care
- Exchange
- TMP Nasdaq
- XNCR Nasdaq
- Market Cap
- TMP 962.3M
- XNCR 1.1B
- IPO Year
- TMP N/A
- XNCR 2013
- Fundamental
- Price
- TMP $64.97
- XNCR $15.85
- Analyst Decision
- TMP Hold
- XNCR Buy
- Analyst Count
- TMP 1
- XNCR 11
- Target Price
- TMP $70.00
- XNCR $23.50
- AVG Volume (30 Days)
- TMP 46.2K
- XNCR 1.1M
- Earning Date
- TMP 10-24-2025
- XNCR 11-05-2025
- Dividend Yield
- TMP 3.99%
- XNCR N/A
- EPS Growth
- TMP 27.02
- XNCR N/A
- EPS
- TMP 5.90
- XNCR N/A
- Revenue
- TMP $316,920,000.00
- XNCR $150,132,000.00
- Revenue This Year
- TMP $17.15
- XNCR $22.09
- Revenue Next Year
- TMP $7.90
- XNCR N/A
- P/E Ratio
- TMP $11.03
- XNCR N/A
- Revenue Growth
- TMP 10.67
- XNCR 38.16
- 52 Week Low
- TMP $54.16
- XNCR $6.92
- 52 Week High
- TMP $79.01
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- TMP 47.91
- XNCR 62.53
- Support Level
- TMP $65.68
- XNCR $13.73
- Resistance Level
- TMP $69.07
- XNCR $16.55
- Average True Range (ATR)
- TMP 1.62
- XNCR 1.05
- MACD
- TMP -0.09
- XNCR 0.07
- Stochastic Oscillator
- TMP 41.71
- XNCR 77.84
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.